{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:04:41Z","timestamp":1782889481349,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012330","name":"Okayama University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005926","name":"Cosmetology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005926","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.biomaterials.2014.01.052","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T08:00:42Z","timestamp":1393833642000},"page":"4508-4516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["The transdermal inhibition of melanogenesis by a cell-membrane-permeable peptide delivery system based on poly-arginine"],"prefix":"10.1016","volume":"35","author":[{"given":"Nanako","family":"Ookubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Michiue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Kitamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Kamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tei-ichi","family":"Nishiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iori","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2014.01.052_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ultras.2013.07.007","article-title":"Sonophoresis in transdermal drug deliverys","volume":"54","author":"Park","year":"2014","journal-title":"Ultrasonics"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500 dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/mp800167a","article-title":"Effect of chemical permeation enhancers on nerve blockade","volume":"6","author":"Simons","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib4","doi-asserted-by":"crossref","first-page":"562924","DOI":"10.1155\/2013\/562924","article-title":"Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status","volume":"2013","author":"Kojima","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib5","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1016\/j.biomaterials.2012.04.056","article-title":"Combining poly-arginine with the hydrophobic counter-anion 4-(1-pyrenyl)-butyric acid for protein transduction in transdermal delivery","volume":"33","author":"Candan","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.drudis.2011.01.012","article-title":"Buccal iontophoresis: an opportunity for drug delivery and metabolite monitoring","volume":"16","author":"Ciach","year":"2011","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.2042-7158.2011.01369.x","article-title":"Microneedles: an emerging transdermal drug delivery system","volume":"64","author":"Bariya","year":"2012","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/cb600127m","article-title":"Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate","volume":"1","author":"Takeuchi","year":"2006","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/cbdd.12008","article-title":"Cell-penetrating peptides as a nonel transdermal drug delivery system","volume":"80","author":"Nasrollahi","year":"2012","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib10","article-title":"Transdermal delivery and cutaneous targeting of antivirals using a penetration enhancer and lysolipid prodrugs","author":"Diblikova","year":"2013","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib11","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.4161\/cbt.8.23.10271","article-title":"Induction of in\u00a0vivo synthetic lethal RNAi responses to treat glioblastoma","volume":"8","author":"Michiue","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib12","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1016\/j.febslet.2005.06.021","article-title":"Ubiquitination-resistant p53 protein transduction therapy facilitates anti-cancer effect on the growth of human malignant glioma cells","volume":"579","author":"Michiue","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib13","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1074\/jbc.M412430200","article-title":"The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction","volume":"280","author":"Michiue","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib14","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/4042","article-title":"Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration","volume":"4","author":"Nagahara","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1600-0625.2011.01315.x","article-title":"Compartmentalization of the human stratum corneum by persistent tight junction-like structures","volume":"20","author":"Haftek","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/nass\/49.1.363","article-title":"Synthesis of a newly peptide nucleic acid that contains tertiary amino groups","volume":"49","author":"Kitamatsu","year":"2005","journal-title":"Nucleic Acids Symp Ser (Oxf)"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib17","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1016\/j.biomaterials.2012.02.049","article-title":"A\u00a0protein transduction method using oligo-arginine (3R) for the delivery of transcription factors into cell nuclei","volume":"33","author":"Hitsuda","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.peptides.2006.11.023","article-title":"Novel peptides with tyrosinase inhibitory activity","volume":"28","author":"Schurink","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-28-13","article-title":"Inhibition of B16 melanoma growth and metastasis in C57BL mice by vaccination with a syngeneic endothelial cell line","volume":"28","author":"Yoshiura","year":"2009","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/jid.2008.376","article-title":"Inulavosin, a melanogenesis inhibitor, leads to mistargeting of tyrosinase to lysosomes and accelerates its degradation","volume":"129","author":"Fujita","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib21","first-page":"323","article-title":"Melanoma cell differentiation induced by lupeol separates into two stages: morphological and functional changes","volume":"63","author":"Ogiwara","year":"2009","journal-title":"J\u00a0Nat Med"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7150\/ijms.5664","article-title":"Wnt5a inhibits the proliferation and melanogenesis of melanocytes","volume":"10","author":"Zhang","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1248\/bpb.17.1417","article-title":"Studies of cuticle drugs from natural sources. II. Inhibitory effects of Prunus plants on melanin biosynthesis","volume":"17","author":"Matsuda","year":"1994","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib24","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bmc.2010.01.005","article-title":"Evaluation of 3,4-dihydroquinazoline-2(1H)-thiones as inhibitors of alpha-MSH-induced melanin production in melanoma B16 cells","volume":"18","author":"Thanigaimalai","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1600-0749.2006.00334.x","article-title":"Hypopigmenting agents: an updated review on biological, chemical and clinical aspects","volume":"19","author":"Solano","year":"2006","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib26","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1021\/jf960428a","article-title":"Improvement of a continuous spectrophotometric method for determining the monophenolase and diphenolase activities of mushroom polyphenol oxidase","volume":"45","author":"Espin","year":"1997","journal-title":"J\u00a0Agric Food Chem"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib27","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1248\/bpb.28.2216","article-title":"Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis","volume":"28","author":"Kim","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib28","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1021\/bi200395t","article-title":"Crystal structure of Agaricus bisporus mushroom tyrosinase: identity of the tetramer subunits and interaction with tropolone","volume":"50","author":"Ismaya","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0962-8924(00)01771-2","article-title":"Protein transduction: unrestricted delivery into all cells?","volume":"10","author":"Schwarze","year":"2000","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.addr.2007.11.001","volume":"60","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ncb0304-189","article-title":"Transduction peptides: from technology to physiology","volume":"6","author":"Joliot","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib32","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1523\/JNEUROSCI.21-16-06000.2001","article-title":"A\u00a0high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation","volume":"21","author":"Matsushita","year":"2001","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nm996","article-title":"Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis","volume":"10","author":"Wadia","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/03639045.2012.684388","article-title":"Transdermal absorption and stability enhancement of salmon calcitonin by Tat peptide","volume":"39","author":"Manosroi","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/17425247.2012.663351","article-title":"Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application","volume":"9","author":"Zhang","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib36","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bbrc.2011.12.084","article-title":"Anti-inflammatory effects of Tat-Annexin protein on ovalbumin-induced airway inflammation in a mouse model of asthma","volume":"417","author":"Lee","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.5483\/BMBRep.2012.45.6.036","article-title":"Suppression of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin inflammation in mice by transduced Tat-Annexin protein","volume":"45","author":"Lee","year":"2012","journal-title":"BMB Rep"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1124\/jpet.111.180042","article-title":"Therapeutic effects on atopic dermatitis by anti-RelA short interfering RNA combined with functional peptides Tat and AT1002","volume":"338","author":"Uchida","year":"2011","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib39","first-page":"2459","article-title":"Tat peptide-admixed elastic liposomal formulation of hirsutenone for the treatment of atopic dermatitis in NC\/Nga mice","volume":"6","author":"Kang","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0017685","article-title":"Expression of a constitutively active calcineurin encoded by an intron-retaining mRNA in follicular keratinocytes","volume":"6","author":"Fujimura","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib41","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/gt.2011.204","article-title":"Topical application of the antiapoptotic TAT-FNK protein prevents aminoglycoside-induced ototoxicity","volume":"19","author":"Kashio","year":"2012","journal-title":"Gene Ther"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib42","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.freeradbiomed.2011.09.036","article-title":"Effects of intracellular superoxide removal at acupoints with TAT-SOD on obesity","volume":"51","author":"Guo","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0928-0987(02)00255-5","article-title":"In\u00a0vitro evaluation of patch formulations for topical delivery of gentisic acid in rats","volume":"18","author":"Bian","year":"2003","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib44","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/03639045.2012.690417","article-title":"Preformulation and formulation of newly synthesized QNT3-18 development of a skin whitening agent","volume":"39","author":"Ki","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.biomaterials.2014.01.052_bib45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1468-2494.2010.00616.x","article-title":"The melanogenesis and mechanisms of skin-lightening agents\u2013existing and new approaches","volume":"33","author":"Gillbro","year":"2011","journal-title":"Int J Cosmet Sci"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961214000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961214000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:58:21Z","timestamp":1758902301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961214000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":45,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0142961214000829"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2014.01.052","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The transdermal inhibition of melanogenesis by a cell-membrane-permeable peptide delivery system based on poly-arginine","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2014.01.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}